CITIUS ONCOLOGY, INC. (CTOR) Stock Profile — Insider Trades & Financials

Revenue$3.9M

Net Income-$5.5M

EPS$-0.06

Gross Margin80.0%

Market Cap$56.7M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Leonard Mazur

CEO & Executive Director

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Founded: 2021
Headquarters: Cranford, New Jersey, United States

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-9.47%

ROA?

-5.03%

D/E Ratio?

0.88

Op. Margin?

-133.17%

📊

Profitability Ratios

Net Margin?

-140.31%

Loading company sections...

CITIUS ONCOLOGY, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness